Maryam Heidarpour1, Mehrbod Vakhshoori2, Mohammad Ali Haghighatpanah3, Leila Ashrafi1, Farzin Khorvash4, Bijan Iraj1. 1. Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. 2. Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. 3. Isfahan University of Medical Sciences, Isfahan, Iran. 4. Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract
BACKGROUND: Common manifestations of coronavirus disease 2019 (COVID-19) from its initial official introduction are mostly related to the respiratory system. However, other rarer presentations are reported nowadays. Case Presentations. We reported three cases of COVID-19-infected patients with rhabdomyolysis as well as two other rarer simultaneous signs, including hypocalcemia (Case 1) and diabetic ketoacidosis (DKA) (Case 2). CONCLUSION: Despite the fact that rhabdomyolysis is an infrequent manifestation of COVID-19, high clinical suspicion is required for proper diagnosis and management of this disease as well as other concurrent rarer presentations, including hypocalcemia and DKA for the prevention of further complications.
BACKGROUND: Common manifestations of coronavirus disease 2019 (COVID-19) from its initial official introduction are mostly related to the respiratory system. However, other rarer presentations are reported nowadays. Case Presentations. We reported three cases of COVID-19-infected patients with rhabdomyolysis as well as two other rarer simultaneous signs, including hypocalcemia (Case 1) and diabetic ketoacidosis (DKA) (Case 2). CONCLUSION: Despite the fact that rhabdomyolysis is an infrequent manifestation of COVID-19, high clinical suspicion is required for proper diagnosis and management of this disease as well as other concurrent rarer presentations, including hypocalcemia and DKA for the prevention of further complications.
Authors: Lakshmi Nathan; Alex L Lai; Jean Kaoru Millet; Marco R Straus; Jack H Freed; Gary R Whittaker; Susan Daniel Journal: ACS Infect Dis Date: 2019-12-10 Impact factor: 5.084
Authors: Luigi Di Filippo; Anna Maria Formenti; Patrizia Rovere-Querini; Michele Carlucci; Caterina Conte; Fabio Ciceri; Alberto Zangrillo; Andrea Giustina Journal: Endocrine Date: 2020-06-12 Impact factor: 3.925